Alex has been part of the teams advising:
- Glencore, CPP Investments and BC, as shareholders, in Viterra Ltd.’s approximately $18 billion business combination with Bunge Ltd.
- Iron Mountain Incorporated in its acquisition of Regency Technologies
- Sanofi in its $2.9 billion acquisition of Provention Bio Inc. and its pending approximately $2.2 billion acquisition of Inhibrx, Inc.
Prior to joining Weil, Alex was a Corporate associate at another international law firm.
Alex received his J.D. from the Benjamin N. Cardozo School of Law and his B.A. from Duke University.